Log in to save to my catalogue

Comparative effectiveness of endothelin receptor antagonists on mortality in patients with pulmonary...

Comparative effectiveness of endothelin receptor antagonists on mortality in patients with pulmonary...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_02b0fd785af9437c86ccddb941e5808f

Comparative effectiveness of endothelin receptor antagonists on mortality in patients with pulmonary arterial hypertension in a US Medicare population: a retrospective database analysis

About this item

Full title

Comparative effectiveness of endothelin receptor antagonists on mortality in patients with pulmonary arterial hypertension in a US Medicare population: a retrospective database analysis

Publisher

London, England: SAGE Publications

Journal title

Pulmonary circulation, 2020-10, Vol.10 (4), p.1-11

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Limited evidence is available on outcomes associated with currently available medications from the endothelin receptor antagonist drug class (bosentan, ambrisentan, and macitentan) in elderly patients with pulmonary arterial hypertension. We evaluated mortality in predominantly elderly patients with pulmonary arterial hypertension in the US taking...

Alternative Titles

Full title

Comparative effectiveness of endothelin receptor antagonists on mortality in patients with pulmonary arterial hypertension in a US Medicare population: a retrospective database analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_02b0fd785af9437c86ccddb941e5808f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_02b0fd785af9437c86ccddb941e5808f

Other Identifiers

ISSN

2045-8940,2045-8932

E-ISSN

2045-8940

DOI

10.1177/2045894020954158

How to access this item